IBM Seeks Niche for Watson for Oncology

Tony Hagen and Rachel Narozniak
Published: Tuesday, Oct 15, 2019
Nathan Levitan, MD, MBA

Nathan Levitan, MD, MBA

After getting off to a rocky start, the artificial intelligence (AI) system that IBM designed for oncology has demonstrated clinical utility in recent studies, generating excitement among AI advocates that the technology may have a productive role as a decision support tool.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication